Back to Search Start Over

Doing more with less: A proposal to advance cigarette packaging regulations in the United States.

Authors :
Shadel WG
Martino SC
Setodji CM
Dunbar M
Jenson D
Wong JC
Falgoust G
Source :
The International journal on drug policy [Int J Drug Policy] 2024 Feb; Vol. 124, pp. 104308. Date of Electronic Publication: 2024 Jan 06.
Publication Year :
2024

Abstract

Cigarette packages are potent marketing tools. Following guidance from the WHO Framework Convention on Tobacco Control, many countries have sought to diminish this marketing power by mandating that (1) large graphic health warnings be affixed to the packages (i.e., text warnings combined with graphic images of the health consequences of smoking) and (2) all packages be fully "plain" in their design (i.e., all packages use the same drab/bland color and font type; no brand logos, other colors, or designs are permitted). Yet, the United States lags other countries in implementing regulations designed to blunt the marketing power of cigarette packages. This is not because of a lack of effort on the part of the Food and Drug Administration, the main governmental body charged with regulating tobacco products in the United States. Rather, it is because the regulatory options that that have been advanced in the country (e.g., graphic health warnings) have not been found - yet - to be legally feasible by its courts. This commentary works through some of the conceptual, practical, and legal issues regarding packaging regulations in the United States. It considers the political and bureaucratic risks involved with issuing new regulations. The overall intent is to prompt our field to think creatively about what is realistic in this regulatory space and to offer a novel perspective that may help move the United States tobacco control community forward in its efforts to reduce the promotional power of cigarette packages.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-4758
Volume :
124
Database :
MEDLINE
Journal :
The International journal on drug policy
Publication Type :
Academic Journal
Accession number :
38184903
Full Text :
https://doi.org/10.1016/j.drugpo.2023.104308